Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Registry of stenting procedures for coronary bifurcation lesions

Official title: International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions

Run by Meshalkin Research Institute of Pathology of Circulation · NCT03450577 · Data updated 2026-11-12

This study is collecting information on how well stenting works for patients with specific heart artery blockages to see what happens to them over five years.

More Coronary Bifurcation Lesion trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment5000 (estimated)
SponsorMeshalkin Research Institute of Pathology of Circulation
Research network
Locations1 site (Novosibirsk, Novosibirsk Oblast)
StatusRecruiting
StartedJanuary 1, 2018
Main results expectedDecember 31, 2021
Study endsDecember 31, 2026
Registry record updatedMarch 11, 2019
Trial IDNCT03450577 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with any type of bifurcation lesion in a major epicardial artery.

Probably not a fit

Patients who refuse to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The International Bifurcation Study is an observational registry that collects real-world data on stenting procedures for patients with coronary bifurcation lesions. It aims to analyze long-term clinical outcomes and identify predictors of adverse events following percutaneous coronary intervention (PCI). Patients who meet the inclusion criteria will undergo PCI according to standard care and will be monitored for five years. This multi-center approach allows for a comprehensive understanding of treatment effectiveness across various healthcare settings.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies and outcomes for patients with coronary bifurcation lesions.

How similar studies have gone: Other studies have shown success in similar observational approaches, indicating the potential for valuable insights from this registry.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Any type of bifurcation lesion in major epicardial artery

Exclusion Criteria:

* Patient refused informed consent to participate in the registry

Where it's running

  • Meshalkin National Research Center
    Novosibirsk, Novosibirsk Oblast, Russia
    Recruiting

Study contacts

  • Principal investigator: Dmitrii Khelimskii, MD — Meshalkin National Medical Research Center
  • Study coordinator: Dmitrii Khelimskii, MD
  • Email: dkhelim@mail.ru
  • Phone: +79137069256

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.